Transfusion Medicine

Papers
(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Author Index24
Issue Information24
19
Drivers of blood use in paediatric trauma: A retrospective cohort study18
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major16
Recruiting racialised youth to a stem cell registry in Canada15
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda13
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage13
Hemolysis during therapeutic plasma exchange: A rare phenomena12
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis12
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach10
Issue Information9
Perinatal clinical management of a rare AB h variant blood group8
All blood discard does not amount to blood wastage—A critical technical reappraisal8
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion8
Plenary session III8
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia7
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene7
7
Issue Information7
Lipidomic changes occurring in platelets during extended cold storage7
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients6
Plenary II6
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient6
SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: Laboratory information management systems: Are we ready for digital transformation?6
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding6
Deviations in red cell blood component temperature during laboratory processing and at blood return monitored by a time–temperature indicator device6
Reducing blood component wastage through targeted interventions: A four‐year retrospective study at a Saudi tertiary hospital6
Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy6
Issue Information6
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status5
Pitfalls of reasoning in hospital‐based transfusion medicine5
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia5
Poster Presentations5
Author index5
Transfusion‐related pulmonary complications in paediatric acute myeloid leukaemia: A case report of transfusion‐associated circulatory overload ( TACO 5
D−− phenotype in a South Indian family: A multicentric approach to workup and management5
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study5
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population5
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia5
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors5
Issue Information4
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation4
4
4
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic4
Acute pancreatitis from a delayed haemolytic transfusion reaction3
3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia3
It is not all anti‐policy attitudes: Viewing blood donation as a means to belong predicts blood donation among men who have sex with men3
A review of immunoglobulin use in a district general hospital setting3
Issue Information3
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐23
Zika virus surveillance post‐epidemic in blood donors from São Paulo, Brazil 2016–20203
Prevalence of anaemia among blood donors in eastern Morocco: The need for pre‐donation haemoglobin assessment3
Implementation of a patient blood management programme for platelet therapy among haemato‐oncology patients—A quasi‐experimental study3
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion3
Improvising neonatal thrombocytopenia management: Insights from split, volume‐reduced, single‐donor apheresis platelets (NeoVRs‐SDAP)3
An accurate genetic assay to identify human neutrophil antigen 2 deficiency3
Review of transfusion practice for beta thalassaemia major patients in Scotland after removal of age criteria for red cell transfusion3
Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline3
Impact of elevated leukocyte levels on ABO blood group typing and cross‐matching3
Determining a safe pre‐transfusion protocol for multiple myeloma patients on anti‐ CD38 treatment3
Lessons learned from the CONCOR‐1 trial3
Systematic literature review and meta‐analysis of concordance and accuracy of pretransfusion immunohematology routine tests3
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio3
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)3
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study3
2
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors2
Evaluating the effects of a hospital utilisation improvement program on platelet transfusions: A pre‐post study2
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour2
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study2
Ferritin‐guided management of blood donors with a marginally low pre‐donation haemoglobin and its effect on the number of donations in the following 3 years2
SARS‐CoV‐2 infection in the blood transfusion setting2
Plenary III2
Issue Information2
Characterisation of RHD and RHCE variations in blood donors from Jazan Province, Southwestern Saudi Arabia2
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’2
Challenges associated with recall and referral strategies for HIV ‐reactive blood donors in India: Insights from a nationwide online survey2
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada2
Double or nothing: Costs of duplicate haematinic ordering in medical inpatients2
Knowledge and attitudes of apheresis donors regarding apheresis blood donation2
Cost analysis of care and blood transfusions in patients with Major Obstetric Haemorrhage in Ireland2
Severe fetal anaemia due to red cell alloimmunisation in a Rhnull woman: A case report2
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) Stream of the BLOOD 2023 Meeting 5th – 8th November 2023, Melbourne, Australia2
Plenary session III2
Two novel variant allele of the RHD gene detected in two Chinese blood donors with the RHD negative phenotype2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures2
Universal new blood cell elution method with extensive phenotyping2
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants2
Plenary session I2
2
Issue Information2
Critical appraisal of knowledge, attitude and practice studies for blood donation in India2
Perceptions of donor screening—Do I always need to tell the truth?2
2
Understanding hepcidin for iron management in pregnancy2
2
Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the United Kingdom2
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study2
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review2
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation2
Issue Information2
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease2
Issue Information2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
Are we missing the true impact of ferritin‐guided donor management?2
2
SARS‐CoV‐2‐associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues2
0.18849301338196